Hardy Kornfeld Selected Research

Interleukin-16 (Interleukin 16)

1/2018	IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.
10/2010	IL-16 promotes T. whipplei replication by inhibiting phagosome conversion and modulating macrophage activation.
1/2006	CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16.
1/2006	Interleukin-16 inhibits interleukin-13 production by allergen-stimulated blood mononuclear cells.
3/2003	Immunomodulatory effect of interleukin-16 on allergic airway inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hardy Kornfeld Research Topics

Disease

43	Tuberculosis (Tuberculoses) 11/2022 - 04/2002
23	Infections 01/2021 - 01/2003
14	Inflammation (Inflammations) 01/2020 - 03/2003
9	Pulmonary Tuberculosis 11/2021 - 01/2014
5	Necrosis 01/2021 - 04/2005
4	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2014
3	Diabetes Mellitus 01/2019 - 01/2016
2	Pneumonia (Pneumonitis) 01/2020 - 01/2018
2	Latent Tuberculosis 01/2019 - 12/2014
2	Hyperglycemia 01/2017 - 11/2014
2	Hypercholesterolemia 06/2012 - 08/2008
1	Immune Reconstitution Inflammatory Syndrome 10/2020
1	Lung Injury 01/2020
1	Hypertrophy 07/2019
1	Insulin Resistance 07/2019
1	Lymph Node Tuberculosis (Scrofula) 11/2018
1	Hemorrhage 01/2018
1	Hemoptysis 01/2017
1	Diabetes Complications 01/2017
1	Noncommunicable Diseases 01/2017
1	Communicable Diseases (Infectious Diseases) 02/2016
1	Pleural Tuberculosis 03/2014
1	Pleural Effusion (Pleural Effusions) 03/2014
1	Pleurisy (Pleuritis) 03/2014
1	Persistent Infection 01/2013

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2020 - 08/2008
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 08/2015
5	ChemokinesIBA 11/2021 - 04/2002
5	AerosolsIBA 07/2019 - 03/2010
5	Interleukin-16 (Interleukin 16)IBA 01/2018 - 03/2003
5	Chemotactic FactorsIBA 08/2015 - 04/2002
4	Pharmaceutical PreparationsIBA 01/2022 - 03/2017
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 08/2008
4	Metformin (Glucophage)FDA LinkGeneric 10/2020 - 01/2018
4	VaccinesIBA 01/2017 - 10/2007
4	AntigensIBA 03/2014 - 11/2007
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2006 - 04/2002
3	Matrix Metalloproteinases (MMPs)IBA 05/2021 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2016
2	EnzymesIBA 01/2021 - 03/2014
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 07/2019
2	InflammasomesIBA 01/2020 - 01/2013
2	Receptor for Advanced Glycation End ProductsIBA 12/2019 - 11/2014
2	LipidsIBA 07/2019 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2018 - 04/2009
2	Streptozocin (Streptozotocin)FDA Link 10/2016 - 06/2010
2	Interferon-gamma (Interferon, gamma)IBA 12/2015 - 03/2014
2	InterferonsIBA 08/2015 - 01/2013
2	Apolipoproteins E (ApoE)IBA 06/2012 - 08/2008
2	CholesterolIBA 06/2012 - 08/2008
2	EpitopesIBA 07/2008 - 10/2007
2	interleukin 16 precursorIBA 09/2005 - 03/2005
1	Metalloproteases (Metalloproteinases)IBA 05/2021
1	Tissue Inhibitor of Metalloproteinase-1IBA 05/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2021
1	Sirtuin 3IBA 01/2021
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	LigandsIBA 12/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 07/2019
1	lipoxin A4IBA 01/2019
1	Thromboplastin (Tissue Factor)IBA 01/2019
1	C-Reactive ProteinIBA 01/2019
1	Inflammation MediatorsIBA 01/2019
1	Leukotriene B4IBA 01/2019
1	EicosanoidsIBA 01/2019
1	Lipopolysaccharide ReceptorsIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	Dinoprostone (PGE2)FDA Link 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 03/2018
1	pristane (pristan)IBA 01/2018
1	Sirtuin 1IBA 03/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	beta-DefensinsIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	CathelicidinsIBA 01/2017
1	Biological ProductsIBA 01/2017
1	AntibodiesIBA 01/2017
1	Antimicrobial PeptidesIBA 01/2017
1	NexusIBA 01/2017
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2017
1	Advanced Glycation End ProductsIBA 01/2017
1	Niacinamide (Nicotinamide)FDA LinkGeneric 10/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2016
1	BCG Vaccine FDA Link 01/2016
1	SolutionsIBA 12/2015
1	p38 Mitogen-Activated Protein KinasesIBA 11/2014
1	ChromatinIBA 11/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2013
1	Interleukin-1 (Interleukin 1)IBA 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2013
1	Chemokine ReceptorsIBA 12/2012
1	Virulence Factors (Pathogenicity Factors)IBA 11/2012
1	lipoarabinomannan (LAM)IBA 11/2012

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2016
2	Aftercare (After-Treatment) 01/2021 - 01/2017
1	Art Therapy 01/2020
1	Microspheres (Microsphere) 12/2016
1	Drug Therapy (Chemotherapy) 01/2016